Juthamas Sukbuntherng
Juthamas Sukbuntherng publishes mostly in Genetics, Molecular Biology and Hematology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and PI3K/AKT/mTOR signaling in cancer.
- World rank
- #768,818 of 7,710,434 ranked researchers
- Rank in United States
- #257,563 of 1,627,098
- Works
- 82
- Citations
- 7.4k
- Citations per work
- 90.4
What does Juthamas Sukbuntherng research?
Juthamas Sukbuntherng's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3744.7%
- Health Sciences3644.2%
- Medicine3644.2%
- Life Sciences911.1%
- 1Genetics18% of their works
- 2Molecular Biology11% of their works
- 3Hematology11% of their works
- 4Pathology and Forensic Medicine7% of their works
- 5Radiology, Nuclear Medicine and Imaging4% of their works
- 6Oncology4% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- PI3K/AKT/mTOR signaling in cancer
- Chronic Myeloid Leukemia Treatments
- Monoclonal and Polyclonal Antibodies Research
- Angiogenesis and VEGF in Cancer
- Immunodeficiency and Autoimmune Disorders
- Neurotransmitter Receptor Influence on Behavior
Which keywords describe Juthamas Sukbuntherng's research?
The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, BCR-ABL, Fc Receptors and Imatinib.
- Primary Immunodeficiency
- Dopamine
- VEGF
- Therapeutic Antibodies
- Imatinib
- BCR-ABL
- Classification
- Chronic Lymphocytic Leukemia
- Rituximab
- Genomic Aberrations
- Lymphoma
- Fc Receptors
- Signaling
- mTOR
- endothelial progenitor cells
- Genetic Mutations
- Serotonin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Rituximab452 topics
- Chronic Lymphocytic Leukemia321 topic
- Genomic Aberrations321 topic
- Classification131 topic
- Lymphoma131 topic
- BCR-ABL91 topic
- Fc Receptors91 topic
- Imatinib91 topic
- Signaling91 topic
- Therapeutic Antibodies91 topic
- mTOR91 topic
- VEGF71 topic
- endothelial progenitor cells71 topic
- Dopamine51 topic
- Genetic Mutations51 topic
- Primary Immunodeficiency51 topic
- Serotonin51 topic
Where does Juthamas Sukbuntherng work?
Juthamas Sukbuntherng's main affiliation in the publication record is Pharmacyclics (United States), United States.
How many publications and citations does Juthamas Sukbuntherng have?
OpenAlex counts 82 works and 7,415 citations for Juthamas Sukbuntherng, an h-index of 28, ranking #768,818 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Juthamas Sukbuntherng. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.